AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer

20Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

The estrogen receptor alpha (ERα) is a steroid receptor that is pivotal in the initiation and progression of most breast cancers. ERα regulates gene transcription through recruitment of essential coregulators, including the steroid receptor coactivator AIB1 (Amplified in Breast Cancer 1). AIB1 itself is an oncogene that is overexpressed in a subset of breast cancers and is known to play a role in tumor progression and resistance to endocrine therapy through multiple mechanisms. Here we review the normal and pathological functions of AIB1 in regard to its ERα-dependent and ERα-independent actions, as well as its genomic conservation and protein evolution. We also outline the efforts to target AIB1 in the treatment of breast cancer.

Cite

CITATION STYLE

APA

Kiliti, A. J., Sharif, G. M., Martin, M. B., Wellstein, A., & Riegel, A. T. (2023). AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer. Frontiers in Endocrinology. Frontiers Media SA. https://doi.org/10.3389/fendo.2023.1250218

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free